Publication | Pharmaceutical Compliance Monitor

Regulatory and Compliance Implications of Orphan Drugs

Edward J. Buthusiem and Gary F. Miller, Jr.

November 24, 2014

Edward Buthusiem and Gary Miller write about drug development and compliance, the Orphan Drug Act, and potential program incentives.

Read the article.


Related Professionals

Edward J. Buthusiem

Managing Director

Washington, DC